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High-output cardiac failure secondary to hepatic involvement is a rare complication of hereditary hemorrhagic telangiectasia
(HHT). Here we report a 43-year-old woman who presented at 29 weeks gestation of her second pregnancy with complications
of right-sided heart failure and preterm labor. After delivery via cesarean section, the patient was found to have intrahepatic
arteriovenous malformations through non-invasive imaging. Subsequently, a family history of vascular malformations and
epistaxis was elucidated and a diagnosis of HHT was made. This case is presented, along with a review of the literature and
discussion of hepatic involvement in HHT with particular focus on the pregnant patient.
Copyright © 2009 Tareq Goussous et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Hereditary hemorrhagic telangiectasia (HHT), also known
as Osler-Weber-Rendu disease, is an autosomal dominant
disorder aﬀecting vascular structures. The prevalence of the
disorder has been found to be from 1 in 2,351 to 1 in
39,216 varying by geography. Its hallmark is telangiectatic
lesions, most frequently involving the skin and mucous
membranes. Visceral involvement is common, with the
lungs, brain, alimentary tract, and liver as the most common
sites of arteriovenous malformations. Patients may present
with epistaxis, cutaneous lesions, gastrointestinal bleeding,
or other symptoms [1].
A 43-year-old G2P2 presented on postpartum day 2
with complaints of severe orthopnea, nocturnal paroxysmal
dyspnea, and lower extremity edema. These symptoms
had begun during the second trimester of pregnancy and
had gradually progressed. Her medical history is positive
for recurrent epistaxis, chronic anemia, and mitral valve
regurgitation.Thepatient’smotherhadahistoryofrecurrent
epistaxis and had experienced pregnancy complications that
were similar to the current symptoms of the index patient.
On review of the mother’s medical records, it was found that
she had been diagnosed with arteriovenous malformations
in her liver through ultrasonography. The maternal aunt was
also reported to have similar complains.
On examination, she had a holosystolic murmur of II/VI
intensitythatwasaudiblethroughouttheprecordium,which
was markedly hyperdynamic. Her abdomen was distended
and her liver was palpable six centimeters below the costal
margin. There was a continuous bruit audible over the liver
and she demonstrated hepatojugular reﬂux. An echocardio-
gram demonstrated normal left ventricular function with an
ejection fraction of 60% with moderate mitral regurgitation
and mild tricuspid regurgitation with structurally normal
valves. There was no evidence of ventricular hypertrophy or
enlargement.
Her laboratory ﬁndings were signiﬁcant for a normo-
chromic, normocytic anemia, decreased albumin (2.8g/dL)
and total protein (4.8g/dL). She had mildly elevated total
bilirubin (1.8mg/dL), aspartate transaminase and alanine
transaminase.
Computerized tomography (CT) and magnetic reso-
nance imaging (MRI) of the abdomen and pelvis per-
formed demonstrated an enlarged, nodular, heterogeneous
liver along with ascites. Two lesions were observed in the2 Cardiology Research and Practice
lungs that were consistent with arteriovenous malformations
(AVMs) (Figure 1). An abdominal ultrasound revealed the
hepatic nodularity to be due to hypervascularity. Spectral
Doppler evaluation of these vessels revealed them to have
mixed arterial and venous waveforms, consistent with multi-
plearteriovenousmalformationsoftheliver.Noenlargement
of the spleen was observed.
Marked symptomatic improvement was demonstrated
afterheartfailuremanagementwithmetoprolol,furosemide,
and spironolactone. She was discharged from the hospital
on postpartum day 14 with her abdominal pain relieved and
lower extremity edema resolving.
The diagnosis of HHT is made through clinical ﬁnd-
ings. Patients have a combination of recurrent epistaxis,
mucocutaneous telangiectases, visceral arteriovenous mal-
formations, and aﬀected ﬁrst-degree family members. The
disease is considered to be present if 3 of these 4 criteria
are met and possible if 2 are present [2]. Radiological
adjuncts to diagnosis include sonography, angiography, CT,
and MRI. The ability to delineate ﬂow through Doppler
modalities makes ultrasonography an appealing technology
for diagnosis of visceral disease and recent eﬀorts have been
made to describe parameters for diagnosis.
It has recently been determined that HHT is a cluster
of autosomally dominant disorders that are the result of
various genetic defects. Speciﬁc genes in which mutations
have been identiﬁed include endoglin and ALK-1, which are
responsible for subtypes HHT-1 and HHT-2, respectively.
It is thought that the diﬀering mutations may be partially
responsible for the heterogeneity of the disease although this
has not been fully characterized [3].
The liver manifestations found in HHT include high
output cardiac failure, portal hypertension, and biliary dis-
ease [4]. Usually the cardiovascular manifestations prevail,
with only mild liver impairment. However, cases have been
described of liver failure due to intrahepatic HHT lesions
[5]. Hepatic involvement in HHT is present in a signiﬁcant
portion of patients with the disease, with estimates of
frequency ranging from 8% to 31% [6]. A meta-analysis
of families reported to have HHT-2 found evidence of
intrahepatic shunting in 13% of the 281 patients [7].
However,sincehepaticlesionsmayoftenbeasymptomatic,it
isdiﬃculttoaccuratelyassesstheprevalenceandsigniﬁcance
of these AVMs. One study found hepatic involvement in 13
of 40 family members who were screened with ultrasound,
but only 2 of these individuals had symptoms attributable to
the lesions [8].
Vascular lesions in the liver can include either hepatic
artery-hepatic vein or hepatic artery-portal vein malfor-
mations. When the anomalous vasculature involves the
portal vein, portal hypertension and the related symptoms
may evolve. The patient may present with ascites, bleeding
varices, and rarely encephalopathy. More commonly, the
disease aﬀects the hepatic artery and vein. First described
in 1971, high-output cardiac failure is the most common
manifestation of large hepatic artery to hepatic vein shunting
[9]. Reported cases of right-heart catheterization in patients
with symptomatic hepatic AVMs have calculated shunts of
24% to 58% of the cardiac output.
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Figure 1: Axial computerized tomography of the chest in lung
window demonstrating a feeding artery and a draining vein to a
nidus of an arteriovenous malformation (arrowhead).
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Figure 2: Axial computerized tomography of the abdomen in a
liver window demonstrating heterogeneous attenuation of the liver
(arrow).
Only 26 cases of symptomatic visceral HHT during
pregnancy have been reported. The majority of these cases
involve pulmonary lesions, with nine reported cases of
hepatic involvement during pregnancy. The cardiovascular
changes of pregnancy-increased intravascular volume and
venousdistensibility,aswellasincreasedcardiacoutput,may
contribute to the enlargement of arteriovenous malforma-
tions during this period. These changes resolve over weeks
to months postpartum. This may explain the spontaneous
resolution of symptoms observed in some of these patients
after delivery [10].Cardiology Research and Practice 3
Therapeutic options for patients with peripartum high-
output cardiac failure secondary to HHT remain controver-
sial. There is evidence that some patients may spontaneously
get better after delivery while in other patients the disease
is progressive. Consequently, a period of conservative man-
agement is warranted in stable patients before considering
invasive therapy. Medical therapy can help optimize cardiac
functionandalleviatesymptoms.Therehasbeenenthusiasm
for transcatheter embolization of hepatic AVMs in the past
[11]. This technique has been reported to be successful
in patients with pulmonary lesions. However, there have
been reports of frequent morbidity and mortality of the
procedure when applied to hepatic AVMs [12]. Alternatively,
liver transplantation has been proposed as a treatment for
intractable right heart failure or in the case of overt liver
dysfunction [13]. This therapy has been eﬀective in resolving
high-output heart failure, although it has its own attendant
mortality and morbidity.
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